MDGL ▼ -0.2% - Madrigal Pharmaceuticals, Inc. $MDGL - Madrigal to Present Multiple Abstracts at AASLD's The Liver Meeting 2026, Including New Real-World Evidence Reinforcing Rezdiffra as a Foundational Therapy for MASH 27-OCT-2026 08:00 AM ET